However, Mn ions can act as immunotherapeutic agents through a variety of pathways, including activation of the immune response through the cGAS–STING pathway, initiation of the Toll-like receptor-4 (TLR4)-associated signaling pathway to reverse the immunosuppressive microenvironment of the tumor, and induction of ICD through CDT. Here, STING1 is linked to neoplasm.